## 4 Evaluation
### Dataset
\begin{table}
\begin{tabular}{c c c} \hline \hline  & PPI Negative & PPI Positive \\ \cline{2-3}  & n = 109 & n = 21 \\ \hline Age & 80.61 \(\pm\) 7.03 & 81.79 \(\pm\) 3.55 \\ \hline Sex & 1(64)/0(45) & 1(18)/0(2) \\ \hline BSA & 1.58 \(\pm\) 0.16 & 1.54 \(\pm\) 0.09 \\ \hline BMI & 24.57 \(\pm\) 4.56 & 23.32 \(\pm\) 1.28 \\ \hline HTN & 1(93)/0(16) & 1(21)/0(0) \\ \hline CAD & 1(20)/0(89) & 1(8)/0(12) \\ \hline DM & 1(47)/0(62) & 1(15)/0(5) \\ \hline SystolicBP & 132.82 \(\pm\) 17.45 & 139.30 \(\pm\) 6.42 \\ \hline DiastolicBP & 73.80 \(\pm\) 12.01 & 71.34 \(\pm\) 5.71 \\ \hline LVOT & 23.40 \(\pm\) 2.74 & 20.98 \(\pm\) 1.70 \\ \hline ValveCode & 1.79 \(\pm\) 0.98 & 2.37 \(\pm\) 0.86 \\ \hline ValveSize & 25.97 \(\pm\) 3.18 & 25.03 \(\pm\) 1.86 \\ \hline LVEF & 59.49 \(\pm\) 14.03 & 60.35 \(\pm\) 13.44 \\ \hline BaselineRBBB & 1(14)/0(95) & 1(5)/0(15) \\ \hline BaselineRhythm & 1(2)/0(107) & 1(0)/0(21) \\ \hline PR & 179.56 \(\pm\) 35.16 & 185.76 \(\pm\) 34.19 \\ \hline FirstdegreeAVblock & 0.11 \(\pm\) 0.31 & 0.26 \(\pm\) 0.40 \\ \hline QRS & 96.29 \(\pm\) 19.82 & 118.56 \(\pm\) 32.81 \\ \hline QRSmorethan120 & 1(13)/0(96) & 1(12)/0(8) \\ \hline DeltaPR & 2.61 \(\pm\) 32.75 & 6.56 \(\pm\) 12.21 \\ \hline DeltaQRS & 16.12 \(\pm\) 25.38 & 30.48 \(\pm\) 25.58 \\ \hline New\_Onset\_LBBB & 1(17)/0(92) & 1(0)/0(21) \\ \hline ASA & 1(71)/0(37) & 1(9)/0(11) \\ \hline AntiPlateletotherthanASA & 1(75)/0(33) & 1(9)/0(11) \\ \hline AntiPlatetherapy & 1(19)/0(90) & 1(11)/0(9) \\ \hline Beta\_Blocker & 1(52)/0(57) & 1(10)/0(10) \\ \hline CCB & 1(49)/0(59) & 1(7)/0(13) \\ \hline ACEi\_ARB & 1(77)/0(31) & 1(5)/0(15) \\ \hline Diuretics & 1(44)/0(65) & 1(0)/0(21) \\ \hline Aldosteroneantagonist & 1(16)/0(93) & 1(1)/0(19) \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Gil Hospital Data Information (n = number of patients). \begin{table}
\begin{tabular}{c c c} \hline \hline  & PPI Negative & PPI Positive \\ \cline{2-3}  & n = 242 & n = 52 \\ \hline Age & 80.16 \(\pm\) 7.66 & 82.77 \(\pm\) 7.37 \\ \hline Sex & 1(120)/0(122) & 1(19)/0(33) \\ \hline BSA & 1.95 \(\pm\) 0.26 & 2.01 \(\pm\) 0.24 \\ \hline BMI & 28.73 \(\pm\) 6.14 & 30.01 \(\pm\) 5.70 \\ \hline HTN & 1(206)/0(36) & 1(50)/0(2) \\ \hline CAD & 1(135)/0(107) & 1(21)/0(31) \\ \hline \hline \end{tabular}
\end{table} 
Table 3: Chris Hospital DeltaPR_HIGH data information (n = number of patients). \begin{table}
\begin{tabular}{c c c} \hline \hline  & PPI Negative & PPI Positive \\ \hline DM & 1(84)/0(158) & 1(14)/0(38) \\ \hline SystolicBP & 131.65 \(\pm\) 19.41 & 133.52 \(\pm\) 20.24 \\ \hline DiastolicBP & 71.16 \(\pm\) 10.54 & 71.30 \(\pm\) 10.05 \\ \hline LVOT & 20.26 \(\pm\) 1.73 & 20.39 \(\pm\) 1.69 \\ \hline ValveCode & 1.93 \(\pm\) 0.95 & 2.21 \(\pm\) 0.80 \\ \hline ValveSize & 27.08 \(\pm\) 3.37 & 27.60 \(\pm\) 3.09 \\ \hline LVEF & 53.69 \(\pm\) 10.83 & 53.02 \(\pm\) 10.18 \\ \hline BaselineRBBB & 1(21)/0(221) & 1(19)/0(33) \\ \hline BaselineRhythm & 1(78)/0(164) & 1(16)/0(36) \\ \hline PR & 182.80 \(\pm\) 26.71 & 189.16 \(\pm\) 28.44 \\ \hline FirstdegreeAVblock & 0.27 \(\pm\) 0.44 & 0.37 \(\pm\) 0.49 \\ \hline QRS & 103.86 \(\pm\) 21.27 & 116.31 \(\pm\) 24.37 \\ \hline QRSmorethan120 & 1(45)/0(197) & 1(23)/0(29) \\ \hline DeltaPR & 25.39 \(\pm\) 14.01 & 31.80 \(\pm\) 23.75 \\ \hline DeltaQRS & 19.60 \(\pm\) 25.79 & 29.49 \(\pm\) 24.37 \\ \hline New\_Onset\_LBBB & 1(67)/0(175) & 1(17)/0(35) \\ \hline ASA & 1(150)/0(92) & 1(33)/0(19) \\ \hline AntiPlateletotherthanASA & 1(106)/0(136) & 1(21)/0(31) \\ \hline AntiPlateTherrapy & 1(201)/0(41) & 1(42)/0(10) \\ \hline Beta\_Blocker & 1(133)/0(109) & 1(30)/0(22) \\ \hline CCB & 1(64)/0(178) & 1(8)/0(44) \\ \hline ACEi\_ARB & 1(97)/0(145) & 1(12)/0(40) \\ \hline Diuretics & 1(151)/0(91) & 1(38)/0(14) \\ \hline Aldosteroneanatomist & 1(31)/0(211) & 1(4)/0(48) \\ \hline \hline \end{tabular}
\end{table} 
Table 3: _Cont._